Publications by authors named "Lzidore S Lossos"
Article Synopsis
- Racial and ethnic minorities are significantly underrepresented in cancer clinical trials, particularly due to restrictive eligibility criteria that often exclude patients who might benefit the most from treatments.
- A study found that up to 24% of patients with diffuse large B-cell lymphoma would be disqualified from recent trials based on five specific lab criteria, leading to worse outcomes and increased deaths among these excluded groups.
- Analysis revealed that Black/African American and Hispanic patients experienced higher rates of ineligibility compared to non-Hispanic White patients, highlighting a critical need to reevaluate how eligibility criteria are established to ensure equitable access to clinical trials across all demographics.
